Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

80.64 -0.32 (-0.40%)
Streaming Delayed Price Updated: 1:57 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
What Happened With Edwards Lifesciences Stock?
Edwards Lifesciences Corporation (NYSE: EW) shares traded higher on Wednesday. The stock surged despite any company-specific news. 
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Edwards Lifesciences Corporation
Via Business Wire
Deep Dive Into Edwards Lifesciences Stock: Analyst Perspectives (14 Ratings)
 
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $31,000 Today
 
Via Benzinga
How Is The Market Feeling About Edwards Lifesciences?
 
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
 
Via Benzinga
Analyst Expectations for Edwards Lifesciences's Future
 
Via Benzinga
$100 Invested In Edwards Lifesciences 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Earnings Scheduled For February 6, 2024
Companies Reporting Before The Bell • BP (NYSE:BP) is projected to report quarterly earnings at $1.05 per share on revenue of $53.50 billion. 
Via Benzinga
Edwards Lifesciences Earnings Preview
 
Via Benzinga
Expert Ratings For Edwards Lifesciences
 
Via Benzinga
Edwards’ EVOQUE Valve Replacement System First Transcatheter Therapy to Earn FDA Approval for Tricuspid Valve
From Edwards Lifesciences Corporation
Via Business Wire
$1000 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Biotech And Medtech Portfolio Notes On A Fed Day
The Fed held rates keeping their future options flexible with no expectations for future cuts. The market did not like it and sold off with the Russell 2000 down 2.45% and the NASDAQ down 2.23% 
Via Talk Markets
Topics Economy
Assessing Edwards Lifesciences: Insights From 14 Financial Analysts
 
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today
 
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
 
Via Benzinga
Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
From Edwards Lifesciences Corporation
Via Business Wire
Wall Street's Top 10 Stock Calls This Week - Saturday, Dec. 2
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the week of Nov. 27 through Dec. 1. 
Via Talk Markets
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years
 
Via Benzinga
Zscaler Posts Q1 Results, Joins argenx, Cool Company And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
U.S. stock futures traded mixed this morning, with the Dow Jones futures gaining around 15 points on Tuesday. 
Via Benzinga
Topics Stocks
Could Ozempic Harm These 3 Medical Device Stocks?
The drug is on track to cause massive competitive shifts in the healthcare sector. 
Via The Motley Fool
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today
 
Via Benzinga
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week. 
Via Benzinga
Topics Economy Stocks
Earnings Scheduled For October 25, 2023
Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion. 
Via Benzinga
Jim Cramer Says This Tech Stock Up More Than 60% In 2023 Is An 'Expensive Stock, But It Is A Good One'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Trade Desk, Inc. 
Via Benzinga
Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact?
Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story. 
Via Investor's Business Daily
Why Edwards Lifesciences Stock Plummeted Today
Investors trade on potential rather than trailing results, and they found the company's top-line guidance wanting. 
Via The Motley Fool
US Stocks Poised For Mixed Start Ahead Of Meta Earnings: Analyst Sees Corporate Profits Providing 'Fundamental Ballast' To Market
With numerous headwinds in play, analysts have stressed the importance of robust corporate profit growth to sustain valuations. 
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback